SCOPUS 정보 검색 플랫폼

Volumn 19, Issue 1, 2012, Pages 21-23

Optimised beta blocker therapy in heart failure: Is there space for additional heart rate control?

(10) Russell, Stuart James a Oliver, Maria b Edmunds, Linda b Davies, Joanne b Rose, Hayley b Llewellyn Griffiths, Helen c Sim, Victor b Raybould, Adrian c Anderson, Richard b Yousef, Zaheer Raza b

a CARDIFF UNIVERSITY (United Kingdom)

b UNIVERSITY HOSPITAL OF WALES (United Kingdom)

c WEST WALES GENERAL HOSPITAL (United Kingdom)

Author keywords

Beta blockers; Heart failure; Heart rate; Ivabradine

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; BLOOD PRESSURE; CLINICAL PROTOCOL; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART HEMODYNAMICS; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; SINUS RHYTHM; TREATMENT OUTCOME;

EID: 84863407347 PISSN: 09696113 EISSN: None Source Type: Journal
DOI: 10.5837/bjc.2012.001 Document Type: Article

Times cited : (6)

References (7)

1
- 0035799381
- Beta-blockers in congestive heart failure. A bayesian meta-analysis
- Brophy JM, Joseph L, Rouleau JL. Beta-blockers in congestive heart failure. A Bayesian meta-analysis Ann Intern Med 2001;134:550-60. (Pubitemid 32245316)
- (2001) Annals of Internal Medicine , vol.134 , Issue.7 , pp. 550-560
- Brophy, J.M.¹ Joseph, L.² Rouleau, J.L.³

2
- 0034104565
- Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF)
- Hjalmarson A, Goldstein S, Fagerberg B et al. Effects of controlled release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 2000;283:1295-302. http://dx.doi.org/10.1001/jama.283.10.1295 (Pubitemid 30129796)
- (2000) Journal of the American Medical Association , vol.283 , Issue.10 , pp. 1295-1302
- Hjalmarson, A.¹ Goldstein, S.² Fagerberg, B.³ Wedel, H.⁴ Waagstein, F.⁵ Kjekshus, J.⁶ Wikstrand, J.⁷ El, A.D.⁸ Vitovec, J.⁹ Aldershvile, J.¹⁰ Halinen, M.¹¹ Dietz, R.¹² Neuhaus, K.-L.¹³ Janosi, A.¹⁴ Thorgeirsson, G.¹⁵ Dunselman, P.H.J.M.¹⁶ Gullestad, L.¹⁷ Kuch, J.¹⁸ Herlitz, J.¹⁹ Riekenbacher, P.²⁰ more..

3
- 0037159310
- Effect of carvedilol on the morbidity of patients with severe chronic heart failure: Results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study
- DOI 10.1161/01.CIR.0000035653.72855.BF
- Packer M, Fowler MB, Roecker EB et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002;106:2194-9. http://dx.doi.org/10.1161/01.CIR.0000035653.72855. BF (Pubitemid 35222212)
- (2002) Circulation , vol.106 , Issue.17 , pp. 2194-2199
- Packer, M.¹ Fowler, M.B.² Roecker, E.B.³ Coats, A.J.S.⁴ Katus, H.A.⁵ Krum, H.⁶ Mohacsi, P.⁷ Rouleau, J.L.⁸ Tendera, M.⁹ Staiger, C.¹⁰ Holcslaw, T.L.¹¹ Amann-Zalan, I.¹² DeMets, D.L.¹³

4
- 0033514046
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
- Anonymous
- Anonymous. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13. http://dx.doi.org/10.1016/S0140-6736(98) 11181-9
- (1999) Lancet , vol.353 , pp. 9-13

5
- 77956612624
- Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study
- Swedberg K, Komajda M, Bohm M et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 2010;376:875-85. http://dx.doi.org/10.1016/S0140-6736(10)61198-1
- (2010) Lancet , vol.376 , pp. 875-885
- Swedberg, K.¹ Komajda, M.² Bohm, M.³

6
- 0142034545
- National Institute for Health and Clinical ExcellenceCG108. London: NICE
- National Institute for Health and Clinical Excellence. CG108. Chronic heart failure. London: NICE, 2003.
- (2003) Chronic Heart Failure

7
- 0034882356
- Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: Putting guidelines into practice
- DOI 10.1016/S1388-9842(01)00173-8, PII S1388984201001738
- McMurray J, Cohen-Solal A, Dietz R et al. Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice. Eur J Heart Fail 2001;3:495-502. http://dx.doi.org/10.1016/S1388-9842(01)00173-8 (Pubitemid 32780528)
- (2001) European Journal of Heart Failure , vol.3 , Issue.4 , pp. 495-502
- McMurray, J.¹ Cohen-Solal, A.² Dietz, R.³ Eichhorn, E.⁴ Erhardt, L.⁵ Hobbs, R.⁶ Maggioni, A.⁷ Pina, I.⁸ Soler-Soler, J.⁹ Swedberg, K.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.